Genetic and immune characteristics of sentinel lymph node metastases and multiple lymph node metastases compared to their matched primary breast tumours

Abstract

Background Patients with breast cancer presenting with single lymph node metastasis (from a sentinel node) experience prolonged survival compared to patients with multiple lymph node metastases (≥3). However, little information is available on the genetic and immunological characteristics of breast cancer metastases within the regional lymph nodes as they progress from the sentinel lymph node (SLN) downstream to multiple regional lymph nodes (MLNs). Methods Genomic profiling was performed using a next-generation sequencing panel covering 520 cancer-related genes in the primary tumour and metastatic lymph nodes of 157 female patients with breast cancer. We included primary tumours, metastatic lymph nodes and adjacent clinically normal lymph nodes (20 patients from the SLN group and 28 patients from the MLNs group) in the whole transcriptome analysis. Findings The downstream metastatic lymph nodes ( P = 0.029) and the primary breast tumours ( P = 0.011) had a higher frequency of PIK3CA mutations compared to the SLN metastasis. We identified a distinct group of 14 mutations from single sentinel node metastasis and a different group of 15 mutations from multiple nodal metastases. Only 4 distinct mutations (PIK3CA, CDK4, NFKBIA and CDKN1B) were conserved in metastases from both lymph node settings. The tumour mutational burden (TMB) was significantly lower in single nodal metastasis compared to the paired primary breast cancer ( P = 0.0021), while the decline in TMB did not reach statistical significance in the MLNs group ( P = 0.083). In the gene set enrichment analysis, we identified 4 upregulated signatures in both primary tumour and nodal metastases from the MLNs group, including 3 Epithelial-mesenchymal transition(EMT) signatures and 1 angiogenesis signature. Both the CD8/Treg ratio and the CD8/EMT ratio were significantly higher in adjacent normal lymph nodes from patients with a single metastasis in the SLN compared with samples from the MLNs group ( P = 0.045 and P = 0.023, respectively). This suggests that the immune defence from the MLNs patients might have a less favourable microenvironment, thus permitting multiple lymph nodes metastasis. Interpretation Single lymph node metastases and multiple lymph node metastases have significant differences in their molecular profiles and immune profiles. The findings are associated with more aggressive tumour characteristics and less favourable immune charactoristics in patients with multiple nodal metastases compared to those with a single metastasis in the sentinel node. Funding This work was supported by funds from High-level Hospital Construction Project (DFJH201921), the National Natural Science Foundation of China (81902828 and 82002928), the Fundamental Research Funds for...

Molecular and immunological characteristics of postoperative relapse in lymph node‐positive esophageal squamous cell cancer

“…In our study, the median TMB was 5.67 muts/mb in primary tumor group and 3.91 muts/mb in lymph nodes group. Lymph node TMB was generally lower than that of the primary tumor, suggesting that the efficacy of ESCC lymph nodes receiving immunotherapy may be inferior to that of the primary lesion, which is consistent with the reports of breast cancer and lung cancer 32,33 …”

“…Lymph node TMB was generally lower than that of the primary tumor, suggesting that the efficacy of ESCC lymph nodes receiving immunotherapy may be inferior to that of the primary lesion, which is consistent with the reports of breast cancer and lung cancer. 32,33 A growing body of research indicates that the tumor microenvironment is essential for immune response regulation, immune escape promotion, angiogenesis facilitation, and metastasis induction. 34,35 Numerous measures have been found to describe the ability of tumor cells to trigger adaptive immunological responses, the immune activation's downstream effects, like the existence of immune cells, and the immune scores' gene expression profile.…”

Tumor-Infiltrating Cytotoxic T Cells and Tumor-Associated Macrophages Correlate With the Outcomes of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer

“…As the major component of TIICs, TAMs were well-known to promote distant metastasis by multiple mechanisms ( 39 , 40 ), and current studies found that the tumor cells present in lymph nodes maybe an important source of systemic metastasis ( 41 , 42 ). In the most recent study by Chen et al, TAMs were found to significantly higher in breast primary tumor with lymph node metastasis compared with tumor tissues without lymph node involvement ( 43 ).…”

High Expression of DNTTIP1 Predicts Poor Prognosis in Clear Cell Renal Cell Carcinoma

“…EMT was one of malignant characteristic and a key foundation of cancer progression. 12 , 13 , 40 Twist1 signaling boosted tumor progression and promoted metastasis in ccRCC. 41 G2M checkpoint had a significant effect on cell proliferation, especially tumors.…”

“…11 Epithelialmesenchymal transition (EMT), is a characteristic of malignant tumor. [12][13][14] Inhibition of tumor EMT can slow down tumor metastasis. 15,16 Target of tyrosine kinase inhibitor (TKI) drugs had been discovered for treatment of metastatic ccRCC patients, 17,18 but it still leads to poor progression and recurrence when incomplete reversal of tumor hypoxia and EMT in ccRCC.…”